Episode Details

Back to Episodes
34. Psilocybin vs Antidepressants with Dr Robin Carhart-Harris

34. Psilocybin vs Antidepressants with Dr Robin Carhart-Harris

Episode 34 Published 5 years, 1 month ago
Description

Robin Heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London, where he has designed several functional brain imaging studies with psilocybin, LSD, MDMA  and DMT, plus a clinical trial of psilocybin for treatment resistant depression. He has over 50 published papers in peer-reviewed scientific journals; two of which were ranked in the top 100 most impactful academic articles of 2016. Robin’s research has featured in major national and international media and he has given a popular TEDx talk.


Does MDMA impact sleep?

What does the brain look like under the influence of LSD?

How do psychedelics change the quality of brain activity? 

Can psilocybin be used to treat depression? 


Psilocybin vs Escitalopram for Major Depressive Disorder  

Stanislav Grof LSD Psychotherapy

Robin’s first paper – Waves of the Unconscious 

Amanda Feilding

Robin’s PhD 

Drugs live – Channel 4

Psilocybin 

LSD 

MDMA

DMT

Psychedelic resting states 

The entropic brain

Homological scaffolds of brain functional networks

The Stoned Ape theory 

DMT Neural Correlates of the DMT experience 

Psilocybin for Treatment-Resistant Depression 

Serotonin and brain function: a tale of two receptors

★ Support this podcast ★
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us